Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution
The second-generation system represents a technological leap forward as it is more user friendly, covers all strut range sizes, and is lighter by 20%.
Company raises $1.5 million to improve clinical outcomes of ischemic stroke patients with a next-generation aspiration catheter.
A panel discussion with US, European, and Israeli investors on raising funds for young companies.
The advisory board members bolster the Vvital team to develop a game-changing mitral valve repair solution
Agriline and Trendlines led the round for this major leap in endoscopic ultrasound-guided biopsy devices for improved diagnosis of gastrointestinal and other solid tumor cancers
A panel discussion with strategic medical device industry players on raising funds and developing new technologies.
Vessi Medical announced that it secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer.
Trendlines Labs Singapore will invent and develop novel medical technologies, innovating and creating value for Trendlines.